Detailed contribution information
| Contribution title | 3005 - Pharmacological and non-pharmacological treatment options for children with (rare) hereditary developmental disorders |
|---|---|
| Contribution code | PS03-19 (P) |
| Authors | |
| Form of presentation | Poster |
| Topic |
|
| Abstract |
Objective In ENCORE, center of expertise in neurocognitive developmental disorders in Rotterdam, The Netherlands, a cross-disciplinary collaboration of several medical disciplines, such as pediatricians, neurologists, motor and speech therapists, psychologists, child and adolescent psychiatrists, and neuroscientists, is offered to children with rare hereditary neurodevelopmental disorders, such as neurofibromatosis type 1, fragile X syndrome, tuberous sclerosis, and Angelman syndrome,. In a majority of these children (c. 60-90%), learning difficulties and behavioral problems play a prominent role, with increased prevalence rates of autism spectrum disorders and attention-deficit/hyperactivity disorders. Some of these disorders are characterized by anxiety and mood disorders. Sleeping problems are prominent (average rate 40%). In most, but not all children, the intelligence is impaired. How can we enhance the potential of the child and the resilience of the parents and vice versa? International guidelines and scientific literature do not always offer practical tools for treatment purposes. In this lecture we will discuss several treatment options, possible contra-indications and promising experimental treatments, both pharmacological and non-pharmacological. Methods Based on actual cases we will discuss both pharmacological and non-pharmacological interventions, such as a support program for adolescents and young adults with a syndrome or chronic condition, and a treatment protocol for children with sleeping disorders. After a short introduction with a critical view on international guidelines and scientific literature, we will return to clinical practice and to how to apply interventions. This lecture also offers an understanding of the practical treatment of children and adolescents with developmental disorders without a syndrome. Conclusions There is still a lot to do in developing and optimizing interventions/treatment in children with (rare) hereditary developmental disorders. This lecture is an attempt to offer some guidance and practical recommendations in this area. |